Skip to main content
SpringerLink
Log in

Cancers of Unknown Origin

  • Chapter
What’s New in Surgical Oncology

Abstract

Cancers of unknown primary origin (CUP), or occult primary tumors, are malignancies, documented in a metastatic localization, without an identified primary origin. This malignant syndrome accounts for approximately 3–5% [1,2] of all cancer diagnosis. An estimated 31,000 patients have been diagnosed with an occult primary tumor during 2001 in the USA [3]. An analysis of the Swedish Family-Cancer Database demonstrated that incidence of CUP was between 6.00 and 6.98 cases per 100,000 from 1987 to 2008 [4]. Herein we report new developments in the diagnosis and treatment of CUP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abbruzzese JL, Abbruzzese MC, Hess KR et al (1994) Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 12(8): 1272–1280

    PubMed  CAS  Google Scholar 

  2. Pavlidis N, Briasoulis E, Hainsworth J et al (2003) Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 39: 1990–2005

    Article  PubMed  CAS  Google Scholar 

  3. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10–29

    Article  PubMed  Google Scholar 

  4. Bevier M, Sundquist J, Hemminki K. (2012) Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis. Eur J Cancer Prev 21(6): 596–601

    Article  PubMed  Google Scholar 

  5. Blaszyk H, Hartmann A, Bjornsson J (2003) Cancer of unknown primary: clinicopathologic correlations. APMIS. 111(12): 1089–94

    Article  PubMed  Google Scholar 

  6. Hillen HF (2000) Unknown primary tumours. Postgrad Med J 76(901): 690–693

    Article  PubMed  CAS  Google Scholar 

  7. NICE — National Collaborating Centre for Cancer (2010) Diagnosis and management of metastatic malignant disease of unknown primary origin Full Guideline July 2010. http://www.nice.org.uk/nicemedia/live/13044/49864/49864.pdf (Accessed 3 November 2012)

  8. Pentheroudakis G, Greco FA, Pavlidis N (2009) Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review. Cancer Treat Rev 35(3): 221–7

    Article  PubMed  CAS  Google Scholar 

  9. Greco FA, Oien K, Erlander M et al (2012) Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes Ann Oncol 23(2): 298–304

    Article  PubMed  CAS  Google Scholar 

  10. Varadhachary GR, Raber MN, Matamoros A et al (2008) Carcinoma of unknown primary with a colon-cancer profile — changing paradigm and emerging definitions. Lancet Oncol 9: 596–599. doi:10.1016/S1470-2045(08)70151-7

    Article  PubMed  Google Scholar 

  11. Stella GM, Senetta R, Cassenti A et al (2012) Cancers of unknown primary origin: current perspectives and future therapeutic strategies. J Transi Med 10:12. doi: 10.1186/1479-5876-10-12

    Google Scholar 

  12. Varadhachary GR, Talantov D, Raber MN et al (20080) Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 26: 4442–4448

    Article  PubMed  CAS  Google Scholar 

  13. Horlings HM, Van Laar R, Kerst J-M et al (2008) Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. J Clin Oncol 26: 4435–4441

    Article  PubMed  CAS  Google Scholar 

  14. Fletcher JW, Djulbegovic B, Soares HP et al (2008) Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 49(3): 480–508

    Article  PubMed  Google Scholar 

  15. Kwee TC, Kwee RM (2009) Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and metaanalysis. Eur Radiol 19(3): 731–744

    Article  PubMed  Google Scholar 

  16. Kumar R, Dhanpathi H, Basu S et al (2008) Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging. Q J Nucl Med Mol Imaging 52(1): 50–65

    PubMed  CAS  Google Scholar 

  17. Smith G, Carroll L, Aboagye EO (2012) New Frontiers in the Design and Synthesis of Imaging Probes for PET Oncology: Current Challenges and Future Directions. Mol Imaging Biol, Sep 5 [Epub ahead of print]

    Google Scholar 

  18. Pavlidis N (2012) Optimal therapeutic management of patients with distinct clinicopathological cancer of unknown primary subsets Ann Oncol 23: x282–x285

    Article  PubMed  Google Scholar 

  19. Bugat R, Bataillard A, Lesimple T et al (2003) FNCLCC. Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002). Br J Cancer 89: S59–66

    Article  PubMed  Google Scholar 

  20. Fizazi K, Greco FA, Pavlidis N et al (2011) Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 22: vi64–vi68

    Article  PubMed  Google Scholar 

  21. National Comprehensive Cancer Network (2012) NCCN Clinical Practice Guidelines in Oncology. Occult Primary (Cancer of Unknown Primary [CUP]) http://www.nccn.org/professionals/physician_gls/pdf/occult.pdf (Accessed 3 November 2012)

  22. Li J, Fadare O, Xiang L et al (2012) Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. J Hematol Oncol 9: 8

    Article  Google Scholar 

  23. Pentheroudakis G, Pavlidis N (2010) Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. Crit Rev Oncol Hematol 75(1): 27–42

    Article  PubMed  Google Scholar 

  24. Ben-Baruch G, Sivan E, Moran O et al (1996) Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III–IV ovarian papillary serous carcinoma. Gynecol Oncol 60(3): 393–6

    Article  PubMed  CAS  Google Scholar 

  25. de Bresser J, deVos B, van der Ent F et al (2010) Breast MRI in clinically and mammographically occult breast cancer presenting with an axillary metastasis: a systematic review. Eur J Surg Oncol 36(2): 114–9

    Article  PubMed  Google Scholar 

  26. Vlastos G, Jean ME, Mirza AN et al (2001) Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 8(5): 425–31

    Article  PubMed  CAS  Google Scholar 

  27. Walker GV, Smith GL, Perkins GH et al (2010) Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer 116(17): 4000–6

    Article  PubMed  Google Scholar 

  28. Wang X, Zhao Y, Cao X (2010) Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases. Breast J 16(1): 32–7

    Article  PubMed  Google Scholar 

  29. Pavlidis N, Pentheroudakis G, Plataniotis G (2009) Cervical lymph node metastases of squamous cell carcinoma from an unknown primary site: a favourable prognosis subset of patients with CUP. Clin Transi Oncol 11(6): 340–8

    Article  Google Scholar 

  30. National Comprehensive Cancer Network (2012) NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers, http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf (Accessed 3 November 2012)

  31. Johansen J, Buus S, Loft A et al (2008) Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck 30(4): 471–8

    Article  PubMed  Google Scholar 

  32. Al-Ibraheem A, Buck A, Krause BJ et al (2009) Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer. J Oncol 2009:208725

    Google Scholar 

  33. Kwee TC, Kwee RM (2009) Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis. Eur Radiol 19(3): 731–744

    Article  PubMed  Google Scholar 

  34. Balaker AE, Abemayor E, Elashoff D, et al (2012) Cancer of unknown primary: does treatment modality make a difference? Laryngoscope 122(6): 1279–82

    Article  PubMed  Google Scholar 

  35. Guarischi A, Keane TJ, Elhakim T (1987) Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 cases. Cancer 59(3): 572–7.

    Article  PubMed  CAS  Google Scholar 

  36. Campos S, Davey P, Hird A et al (2009) Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma. Curr Oncol 16(1): 62–6

    PubMed  CAS  Google Scholar 

  37. Beckers F, Ludwig C, Cerinza J et al (2009) Der pulmonale Rundherd bei maligner Grunderkrankung — nicht zwingend eine Metastase des Primärtumors. Pneumologie 63(12): 693–696

    Article  PubMed  CAS  Google Scholar 

  38. Savage NM, Alleyne CH, Vender JR et al (2011) Dural-based metastatic carcinomas mimicking primary CNS neoplasia: report of 7 cases emphasizing the role of timely surgery and accurate pathologic evaluation. Int J Clin Exp Pathol 4(5): 530–40

    PubMed  Google Scholar 

  39. Adam R, Chiche L, Aloia T et al (2006) Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases. Annals of Surgery 244(4): 524–535

    PubMed  Google Scholar 

  40. Nieder, C, Spanne, O, Mehta, MP et al (2011) Presentation, patterns of care, and survival in patients with brain metastases. Cancer 117: 2505–2512

    Article  PubMed  Google Scholar 

  41. Aizenberg MR, Fox BD, Suki D et al (2012) Surgical management of unknown primary tumors metastatic to the spine. J Neurosurg Spine 16(1): 86–92

    Article  PubMed  Google Scholar 

  42. Ozeki Y, Abe Y, Kita H et al (2011) A case of primary lung cancer lesion demonstrated by F-18 FDG positron emission tomography/computed tomography (PET/CT) one year after the detection of metastatic brain tumor. Oncol Lett 2(4): 621–623

    PubMed  Google Scholar 

  43. Niranjan A, Kano H, Khan A et al (2010) Radiosurgery for brain metastases from unknown primary cancers. Int J Radiat Oncol Biol Phys 77(5): 1457–62

    Article  PubMed  Google Scholar 

  44. Hart MG, Grant R, Walker M et al (2007) Surgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastases. Cochrane Database of Systematic Reviews 2007, Issue 2

    Google Scholar 

  45. Kyritsis AP, Markoula S, Levin VA (2012) A systematic approach to the management of patients with brain metastases of known or unknown primary site. Cancer Chemother Pharmacol 69(1): 1–13

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical and Surgical Scineces, University of Brescia, Italy

    Gian Luca Baiocchi

  2. Local Healthcare Unit ULSS 19 — Veneto, Adria, Italy

    Ferdinando Agresta

  3. Division of General Surgery, Andosilla Hospital, Civita Castellana (Viterbo), Italy

    Fabio Cesare Campanile

  4. Laparoscopic Surgical Unit, M.Mellini Hospital, Chiari (Brescia), Italy

    Nereo Vettoretto

Authors
  1. Fabio Cesare Campanile
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gian Luca Baiocchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nereo Vettoretto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ferdinando Agresta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabio Cesare Campanile .

Editor information

Editors and Affiliations

  1. General, Emergency and Minimally Invasive Surgery, Careggi Hospital, Florence, Italy

    Andrea Valeri , Carlo Bergamini  & Jacopo Martellucci ,  & 

  2. Local Healthcare Unit ULSS 19 - Veneto, Adria, Italy

    Ferdinando Agresta

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Italia

About this chapter

Cite this chapter

Campanile, F.C., Baiocchi, G.L., Vettoretto, N., Agresta, F. (2013). Cancers of Unknown Origin. In: Valeri, A., Bergamini, C., Agresta, F., Martellucci, J. (eds) What’s New in Surgical Oncology. Springer, Milano. https://doi.org/10.1007/978-88-470-5310-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5310-6_17

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5309-0

  • Online ISBN: 978-88-470-5310-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation